Methods of using regenerative cells in the treatment of renal diseases and disorders
Abstract
Cells present in processed lipoaspirate tissue are used to treat patients, including patients with renal conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in processed lipoaspirate are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic renal benefit.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating impaired renal function in a patient, comprising:
identifying a patient with impaired renal function; and providing to the patient's renal vasculature an amount of a concentrated population of cells comprising adipose-derived stem cells sufficient to improve function of the kidney of said patient.Join the waitlist — get patent alerts
Track US2017136066A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.